4//SEC Filing
Valliant John 4
Accession 0001209191-23-002499
CIK 0001805890other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:46 AM ET
Size
5.3 KB
Accession
0001209191-23-002499
Insider Transaction Report
Form 4
Valliant John
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-05+500,000→ 500,000 totalExercise: $3.75Exp: 2033-01-04→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments beginning on February 5, 2023.
Documents
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001813574
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 6:46 AM ET
- Size
- 5.3 KB